A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...
By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.
The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
Here's a rundown of some of the multibillion-dollar spending pledges made by companies since President Trump took office. Apple: The iPhone maker pledged to spend more than $500 billion over four ...
People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback